Products

Product Portfolio

Aditri product range is diverse, with a presence in key therapeutic segments such as infectious diseases (HIV/AIDS, TB, Hepatitis), anti-diabetics, and cardiovascular. Our portfolio is diverse and specializes in the development and manufacturing of pharmaceutical actives. Our product portfolio includes latest triple-combination drugs for first- and second-line treatment for adults and pediatrics. Diverse presence across infectious disease and specialty segments.

Official Therapeutic Focus

Diverse presence across infectious disease and specialty segments.

Aditri product range is diverse, with a presence in key therapeutic segments such as infectious diseases (HIV/AIDS, TB, Hepatitis), anti-diabetics, and cardiovascular. Our portfolio is diverse and specializes in the development and manufacturing of pharmaceutical actives. Our product portfolio includes latest triple-combination drugs for first- and second-line treatment for adults and pediatrics.

HIV/AIDS

Anti-Retroviral (ARV)

First and second-line treatment for HIV/AIDS in adults and pediatrics. PEPFAR-eligible, WHO-prequalified APIs.

TB Control

Tuberculosis (TB)

Specialized APIs for high-risk TB patients including drug-resistant strains. Meeting global WHO standards.

Liver Health

Hepatitis

Chronic and acute Hepatitis B (HBV) and C (HCV) treatment APIs for global generic markets.

Generics

Generic API

Niche pharmaceutical actives for the global generic industry. USFDA and SRA-market ready.

Therapeutic Areas

HIV/AIDS, tuberculosis, hepatitis, and generics.

Additional segments include Anti-diabetics, Cardiovascular, Pharmaceutical actives.

HIV/AIDS

Anti-Retroviral (ARV)

HIV (human immuno deficiency virus) is a virus that damages the cells in your immune system and weakens ability to fight everyday infections and disease. AIDS (acquired immune deficiency syndrome) is the name used to describe a number of potentially life-threatening infections and illnesses that happen when immune system has been severely damaged by the HIV virus.

Tuberculosis

Tuberculosis (TB)

Tuberculosis (TB) is a serious illness that mainly affects the lungs. The cause tuberculosis is a type of bacteria. Tuberculosis can spread when a person with the illness coughs, sneezes. These can put tiny droplets with the germs into the air, another person breathing in the droplets and the germs enter lungs. Tuberculosis spreads easily where people gather in crowds or where people live in crowded conditions. People with HIV/AIDS and other people with weakened immune systems have a higher risk of catching tuberculosis than people with typical immune systems.

Hepatitis

Hepatitis

Hepatitis B is a serious liver infection caused by the hepatitis B virus (HBV). For most people, hepatitis B is short term, also called acute, and lasts less than six months. But for others, the infection becomes chronic, meaning it lasts more than six months. Having chronic hepatitis B increases your risk of developing liver failure, liver cancer or cirrhosis - a condition that permanently scars the liver. Most adults with hepatitis B recover fully, even if their symptoms are severe. Infants and children are more likely to develop a long-lasting hepatitis B infection. This is known as a chronic infection.

Aditri has been successfully audited by WHO-PQ in July 2026.Aditri holds the Market Authorization (MA) for Finished Dosages and select APIs.Aditri has been successfully audited by WHO-PQ in July 2026.Aditri holds the Market Authorization (MA) for Finished Dosages and select APIs.
✦ API - WHO-PQ✦ Dosages - USFDA✦ WHO-Geneva✦ MHRA✦ SAPHRA✦ EU GMP✦ BA/BE - USFDA✦ MHRA/EU GMP✦ API - WHO-PQ✦ Dosages - USFDA✦ WHO-Geneva✦ MHRA✦ SAPHRA✦ EU GMP✦ BA/BE - USFDA✦ MHRA/EU GMP